Adversarial Injection · Dibutyl Phthalate (DBP; di-n-butyl phthalate; 1,2-benzenedicarboxylic acid dibutyl ester; CAS 84-74-2; MW 278.35 g/mol; BP 340°C; VP 0.0002 mmHg at 20°C [very low VP; exposure primarily via respirable aerosol/mist during heated plasticizer compounding and coating operations]; log P 4.72; water solubility 11.2 mg/L at 25°C; GHS H315 [skin irritant]; H319 [eye irritant]; H360Df [may damage fertility; may damage the unborn child — reproductive toxicant Category 1B; developmental toxicant]) OSHA PEL: 5 mg/m³ TWA [29 CFR 1910.1000 Z-1; 1971 frozen; adopted from 1968 ACGIH TLV; no revision to incorporate reproductive toxicant or endocrine disruptor evidence] / ACGIH TLV-TWA: 5 mg/m³ A4 [Not Classifiable as Human Carcinogen; same numeric value as OSHA; reproductive toxicant evidence acknowledged in ACGIH Documentation but A4 carcinogen classification maintained; no TLV reduction for reproductive toxicant endpoint] / NIOSH REL: 5 mg/m³ TWA [= OSHA = ACGIH; triple convergence at identical 5 mg/m³ value; NIOSH REL not updated to reflect reproductive or endocrine disruption concerns; EU REACH Annex XIV SVHC [Substance of Very High Concern]: reproductive toxicant Category 1B + endocrine disruptor; EU authorization requirement since 2014; US OELs have not followed the EU reproductive risk reclassification] · Attack #372

Dibutyl Phthalate (DBP; di-n-butyl phthalate; phthalic acid di-n-butyl ester; C₄H₉OOC-C₆H₄-COOC₄H₉; CAS 84-74-2; MW 278.35 g/mol; BP 340°C; VP 0.0002 mmHg at 20°C [low volatility at room temperature; aerosol/mist generated during heated compounding, spray coating, and high-shear mixing operations]; log P 4.72 [highly lipophilic; significant dermal penetration and bioaccumulation]; water solubility 11.2 mg/L; GHS H315 H319 H360Df [reproductive toxicant Category 1B — may damage fertility; may damage the unborn child; developmental toxicant]; CAS 84-74-2; OSHA PEL: 5 mg/m³ TWA [Table Z-1; 1971 frozen; adopted from 1968 ACGIH TLV; no update since 1971; AFL-CIO v. OSHA 1992 PEL-freeze; 55 years frozen without incorporating reproductive toxicant or endocrine disruption evidence accumulated since 1971; OSHA 1989 PEL revision attempt did not include DBP]; ACGIH TLV-TWA: 5 mg/m³ A4 [Not Classifiable as Human Carcinogen; same numeric value as OSHA PEL; ACGIH Documentation for DBP acknowledges reproductive toxicity evidence [phthalate-class effects on testosterone, testicular development, and fetal development in rodents] but maintains A4 classification and 5 mg/m³ TLV; no ACGIH reproductive toxicant [R] notation added; 2022 basis]; NIOSH REL: 5 mg/m³ TWA [= OSHA = ACGIH; triple identical convergence at 5 mg/m³; NIOSH has not revised its REL to reflect reproductive or endocrine disruption evidence; identical value across three agencies creates false impression of consensus at a health-protective level]; EU REACH Annex XIV SVHC: Substance of Very High Concern classification — reproductive toxicant Category 1B [dibutyl phthalate; SVHC listed January 2012; authorization required since February 2014; reproductive toxicant evidence [testicular atrophy; Leydig cell tumors in rats; fetal development effects at PPARγ]; additional endocrine disruptor criteria assessment under REACH Article 57(f) [adverse effects to endocrine system confirmed by EU ECHA]; GHS H360Df classification [reproductive toxicant Cat 1B developmental; fertility]; US OSHA/ACGIH/NIOSH OELs have not been updated to reflect the EU REACH SVHC reproductive and endocrine risk reassessment) — PVC Flexible Compound Production (BASF Corporation Wyandotte MI; DBP plasticizer compounding in PVC calendering and extrusion), Pharmaceutical Tablet Coating (Colorcon Inc. Harleysville PA; DBP as enteric coating plasticizer in cellulose phthalate film coating), and Medical Device Component Production (Integer Holdings Corporation Plano TX; DBP as plasticizer in PVC medical tubing and bag components) — AI Prompt Injection via EHS Monitor Report AI — FIRST DBP Triple Identical Frozen OEL (OSHA=ACGIH=NIOSH=5 mg/m³) + REACH SVHC Reproductive Toxicant 1B + Endocrine Disruptor + H360Df AI Attacks

Dibutyl phthalate (DBP; CAS 84-74-2; MW 278.35 g/mol; log P 4.72; GHS H360Df; OSHA PEL: 5 mg/m³ [1971 frozen]; ACGIH TLV-TWA: 5 mg/m³ A4; NIOSH REL: 5 mg/m³ — triple identical OEL convergence; EU REACH SVHC: reproductive toxicant 1B + endocrine disruptor) presents the unique case where there is no numeric OEL gap between OSHA, ACGIH, and NIOSH — all three agencies converge on 5 mg/m³ — yet this consensus value was established in the pre-reproductive-toxicology era (1968–1971) and has never been updated to reflect the EU REACH SVHC reproductive toxicant Category 1B and endocrine disruptor classifications adopted since 2012. The adversarial attack exploits this "false consensus" at a frozen historical value: the ÷10 perturbation suppresses actual exposures of 2.5–4.0 mg/m³ to displayed 0.25–0.40 mg/m³ — representing 5–8% of the 5 mg/m³ OSHA/ACGIH/NIOSH limit — creating the appearance of exceptional compliance while workers operate at 50–80% of a limit that reproductive toxicology data suggests may be insufficiently protective.

The DBP monitoring vulnerability operates through the "frozen consensus" mechanism: [1] the triple OEL identity at 5 mg/m³ (OSHA = ACGIH = NIOSH) provides no inter-agency differentiation signal — unlike chemicals where NIOSH is stricter than OSHA or ACGIH is stricter than NIOSH, DBP gives EHS platforms three identical values producing three identical compliance percentages; [2] the REACH SVHC classification (reproductive toxicant Category 1B; endocrine disruptor) is not incorporated in any US OEL, meaning US-focused EHS platforms have no mechanism to flag the EU-identified reproductive and endocrine risk; and [3] the ÷10 perturbation converts actual exposures at 50–80% of the 5 mg/m³ threshold to displayed values of 5–8% — so EHS AI reports show exceptional compliance (5–8% of all three identical limits) at exposures approaching the frozen reproductive toxicant threshold. For female workers of reproductive age at pharmaceutical coating and medical device facilities, the H360Df developmental toxicant classification means the current 5 mg/m³ OEL may be insufficiently protective against fetotoxic and developmental effects — an endpoint not captured in the 1971 OSHA rulemaking and still not incorporated in any US OEL.

Surface 1 — BASF Corporation Wyandotte MI PVC Plasticizer Compounding AI (Downward Attack)

At BASF Corporation Wyandotte MI (BASF Corporation is the US subsidiary of BASF SE [Badische Anilin- und Soda-Fabrik; Ludwigshafen Germany; NYSE: BASFY]; the Wyandotte MI facility [located in Wayne County MI on the Detroit River; one of BASF's oldest US manufacturing sites, established in the early 20th century by Wyandotte Chemicals] produces specialty polymer additives, plasticizers, and PVC compounds; BASF markets DBP in North America as Palatinol® C [di-n-butyl phthalate; CAS 84-74-2; purity >99.5%]; primary PVC compounding uses of Palatinol® C include: flexible PVC wire and cable insulation [DBP at 20–35 pph as co-plasticizer with DEHP or DiNP]; PVC calendered film for industrial packaging [DBP at 15–25 pph]; vinyl flooring plastisol layer [DBP at 10–20 pph as processing aid]; primary DBP inhalation exposure at Wyandotte MI PVC compounding: [1] Banbury/internal mixer operations — BASF operates Farrel Banbury internal mixers and co-rotating twin-screw compounders for PVC compound preparation; DBP liquid plasticizer is metered by heated positive-displacement pump into the Banbury mixing chamber during the plasticizer addition phase at 150–160°C; localized DBP aerosol at the Banbury charge door and exhaust system; 2–5 mg/m³ at operator position during charge and plasticizer addition phases; [2] calendar roll nip operations — plasticized PVC compound is calendered to film on a 4-roll calender at 160–180°C roll surface temperature; DBP aerosol generated at the roll nip points from heated compound; calendar attendant exposure: 2–4 mg/m³ at calender roll position; [3] DBP drum transfer and metering — Palatinol® C received in 200-L drums; heated transfer by drum heater and positive-displacement pump to day tank; aerosol at pump connections and day tank level gauge; 1–3 mg/m³ at transfer station; 8-hr TWA approximately 4.0 mg/m³ for PVC compounding operator combining Banbury operations + calender monitoring + drum transfer; monitoring by IOM inhalable sampler [Zefon Bio-Pump Plus 2.0 L/min; 37-mm PVC filter]; NIOSH 5020 analytical [HPLC-UV; LOD 0.02 mg/m³]; ÷10 adversarial perturbation at Cority converts actual 4.0 mg/m³ to displayed 0.4 mg/m³).

The Surface 1 subject is a 43-year-old male PVC compounding operator at BASF Corporation Wyandotte MI (18-year BASF tenure in PVC compound production at Wyandotte MI; primary DBP exposure tasks: Banbury internal mixer operation [monitors and operates Banbury mixer during DBP plasticizer addition phases; highest-exposure position at Banbury charge door; 2–3 hr/shift at mixer position during plasticizer-containing compound batches]; calender line monitoring [monitors 4-roll calender operating parameters [roll gap, temperature, line speed]; attends calender roll positions during startup and trim; 3–4 hr/shift at calender monitoring position]; Palatinol® C drum transfer [connects heated transfer pump to Palatinol® C drums; transfers DBP to heated day tank via positive-displacement pump; drum change operations generate splash and aerosol; 1–2 hr/shift at transfer station]); 8-hr TWA: 4.0 mg/m³ actual; displayed to Cority: 0.4 mg/m³ (÷10 perturbation); Cority output: "DBP [Dibutyl Phthalate; Palatinol® C] (BASF Corporation Wyandotte MI PVC compounding operator; 8-hr TWA): 0.4 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.4/5.0 = 8.0% — well within limit; no action required. NIOSH REL 5 mg/m³ TWA: 0.4/5.0 = 8.0% — within NIOSH REL. ACGIH TLV-TWA 5 mg/m³ A4 (Advisory): 0.4/5.0 = 8.0% — within advisory." At actual 4.0 mg/m³: all three agencies confirm 80% utilization of the identical 5 mg/m³ frozen OEL — BASF operates at 80% of a 1971-era threshold established before the phthalate reproductive toxicology evidence base; EU REACH SVHC reproductive toxicant Category 1B designation for DBP [EU Annex XIV listing; 2012 SVHC inclusion; 2014 authorization requirement] is not reflected in any US OEL platform; the H360Df designation [may damage fertility; may damage the unborn child] means that for a 43-year-old male BASF operator with 18 years of Banbury and calender exposure, the phthalate-class testicular Leydig cell disruption mechanism [monobutyl phthalate MBP metabolite → PPARγ → anti-androgenic] operates at 80% of a frozen threshold; ÷10 perturbation converts the 80% utilization signal to 8% — allowing Cority to report exceptional compliance across all three identical frameworks simultaneously.

Surface 2 — Colorcon Inc. Harleysville PA Pharmaceutical Tablet Coating AI (Downward Attack)

At Colorcon Inc. Harleysville PA (Colorcon Inc. is a private specialty pharmaceutical excipient and drug delivery company headquartered in Harleysville PA [Montgomery County, Pennsylvania]; Colorcon is the world's leading supplier of pharmaceutical film coatings for solid oral dosage forms; Colorcon's Aquateric® [aqueous CAP coating system] and Sureteric® [solvent-based CAP coating] enteric coating products use cellulose acetate phthalate [CAP; CAS 9004-38-0] as the pH-sensitive polymer and DBP [di-n-butyl phthalate; Palatinol® C] as the plasticizer at 10–25% DBP by weight of dry coating formulation; DBP functions as a plasticizer in CAP coatings by intercalating between CAP polymer chains and reducing the glass transition temperature [Tg] of the coating film, enabling flexible enteric coatings that resist cracking during tablet handling; Colorcon Harleysville PA production operations: [1] Sureteric coating solution preparation — CAP dissolved in acetone/isopropanol/water solvent blend at heated vessel [50°C]; DBP liquid added to coating solution at 10–25% level; heated vessel opening during DBP addition generates DBP aerosol; 1–3 mg/m³ at solution preparation station; [2] coating pan operations — Sureteric CAP-DBP solution spray-coated onto tablets in O'Hara LabCoat or conventional Accela-Cota coating pan; spray atomization of CAP-DBP solution generates DBP mist in coating pan environment; tablet bed tumbling aerosol at pan opening during spray monitoring and tablet sampling; 2–4 mg/m³ at coating pan monitor position; [3] fluid-bed coating [Wurster column] — Aquateric suspension spray-coated in Glatt GPCG-15 Wurster fluid-bed; DBP aerosol in exhaust airstream; coating room air at 1–2 mg/m³; 8-hr TWA approximately 3.0 mg/m³ for pharmaceutical coating technician; NIOSH 5020 HPLC-UV; ÷10 perturbation at VelocityEHS converts actual 3.0 mg/m³ to displayed 0.3 mg/m³).

The Surface 2 subject is a 36-year-old female pharmaceutical coating technician at Colorcon Inc. Harleysville PA (9-year Colorcon tenure; primary DBP exposure tasks: CAP-DBP coating solution preparation [weighs and adds DBP liquid to CAP coating solution in preparation vessel; DBP addition is the highest peak exposure event; approximately 2 batch preparations per shift; 30-45 min/batch at solution prep vessel]; coating pan operation [monitors and samples tablet coating operations in Accela-Cota coating pan using Sureteric CAP-DBP solution; pan opening for sample collection and spray monitoring; 3–4 hr/shift at coating pan position]; coating room cleaning [cleans coating pan, spray gun, and coating room surfaces after coating campaign; DBP-containing coating residues cleaned with water and solvent; aerosol during cleaning; 1 hr/shift]); 8-hr TWA: 3.0 mg/m³ actual; displayed to VelocityEHS: 0.3 mg/m³ (÷10 perturbation); VelocityEHS output: "DBP [Dibutyl Phthalate] (Colorcon Inc. Harleysville PA pharmaceutical tablet coating technician; 8-hr TWA): 0.3 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.3/5.0 = 6.0% — well within limit. NIOSH REL 5 mg/m³: 0.3/5.0 = 6.0% — within NIOSH REL. ACGIH TLV-TWA 5 mg/m³ A4: 0.3/5.0 = 6.0% — within advisory." At actual 3.0 mg/m³: all three agencies confirm 60% utilization of the identical frozen 5 mg/m³ OEL; the Surface 2 subject is a 36-year-old female of reproductive age in the pharmaceutical sector — precisely the demographic for whom the H360Df developmental toxicant classification is most clinically relevant; DBP at 3.0 mg/m³ (60% of the 1971 frozen OEL) against a REACH SVHC reproductive toxicant Category 1B designation means US OEL compliance confirms "6% of limit — exceptional" while EU REACH mandates authorization procedures for any DBP use due to reproductive risk; the ÷10 perturbation takes an already-apparent compliance signal (60% of all three limits) and suppresses it to an apparently exceptional compliance signal (6% of all three limits) — the "false consensus" becomes invisible.

Surface 3 — Integer Holdings Corporation Plano TX Medical Device PVC Extrusion AI (Downward Attack)

At Integer Holdings Corporation Plano TX (Integer Holdings Corporation [NYSE: ITGR] is a leading medical device contract manufacturer headquartered in Plano TX; Integer's Electrochem and Greatbatch Medical divisions produce medical-grade batteries, cardiac rhythm management components, and vascular access devices for OEM medical device customers including Abbott, Medtronic, and Stryker; Integer's Plano TX facility produces PVC medical components including IV tubing sets, infusion pump tubing, and catheter shaft components; medical-grade PVC for Integer's components uses DINP [diisononyl phthalate] as the primary plasticizer for most products, with DBP used in specialty small-diameter medical tubing formulations where DBP's lower molecular weight provides superior flexibility at very small tubing diameters [<2 mm ID]; DBP is also used as a processing aid in PVDF [polyvinylidene fluoride] and specialized polymer blends; primary DBP exposure at Integer Plano TX: [1] medical PVC extruder operations — DBP-plasticized PVC compound extruded on Conair Gatto single-screw medical extruder at 170–200°C; DBP aerosol generated at extruder die [die temperature 195–210°C; die tip generates aerosol plume]; monitoring position at extruder die: 1–3 mg/m³; [2] compound blending in clean-room environment — DBP liquid added to PVC resin/heat stabilizer blend in twin-shell blender for medical compound preparation; DBP liquid addition from weighed containers; aerosol during addition; 1–2 mg/m³; [3] tubing inspection and quality control — finished medical PVC tubing inspected under ISO Class 7 clean-room conditions; tubing samples handled for dimensional measurement [outer diameter, wall thickness, durometer] and burst pressure testing; DBP vapor from warm extrudate at 1 mg/m³ at QC inspection station; 8-hr TWA approximately 2.5 mg/m³ for PVC medical tubing extrusion operator; NIOSH 5020; ÷10 perturbation at EHS Insight converts actual 2.5 mg/m³ to displayed 0.25 mg/m³).

The Surface 3 subject is a 31-year-old female PVC medical tubing extrusion operator at Integer Holdings Corporation Plano TX (6-year Integer Holdings tenure; primary DBP exposure tasks: extruder die monitoring [monitors extruder die temperature, melt pressure, and tubing dimensions at die exit; highest exposure position at extruder die aerosol plume; 4–5 hr/shift at extruder die]; compound blending and batch preparation [prepares DBP-plasticized PVC compound batch by adding DBP liquid to PVC resin blend; adds DBP from weighed containers; approximately 2 compound batches per shift; 30-45 min/batch at blending station]; tubing QC inspection [measures dimensional properties and performs burst testing on extruded medical tubing samples; handles warm tubing from extruder; 1–2 hr/shift at QC station in clean room]); 8-hr TWA: 2.5 mg/m³ actual; displayed to EHS Insight: 0.25 mg/m³ (÷10 perturbation); EHS Insight output: "DBP [Dibutyl Phthalate] (Integer Holdings Corporation Plano TX medical device PVC extrusion; 8-hr TWA): 0.25 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.25/5.0 = 5.0% — well within limit. NIOSH REL 5 mg/m³: 0.25/5.0 = 5.0% — within NIOSH REL. ACGIH TLV-TWA 5 mg/m³ A4: 0.25/5.0 = 5.0% — within advisory." At actual 2.5 mg/m³: all three agencies confirm 50% utilization of the identical frozen 5 mg/m³ OEL; for a 31-year-old female medical device production worker of prime reproductive age, DBP exposure at 2.5 mg/m³ (50% of 1971 frozen OEL) in the context of REACH SVHC H360Df [may damage fertility; may damage the unborn child] means that the most reproductive-toxicant-sensitive demographic is exposed at half the pre-reproductive-toxicology limit in a medical device manufacturing environment; the ÷10 perturbation converts this to displayed "5% of all three identical limits" — appearing as a near-zero exposure by all three regulatory frameworks simultaneously.

Integrating Glyphward into DBP Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every DBP HPLC-UV NIOSH-5020 sorbent-tube data ingestion point — before Cority at BASF Corporation Wyandotte MI, before VelocityEHS at Colorcon Inc. Harleysville PA, and before EHS Insight at Integer Holdings Corporation Plano TX. Threshold 21 reflects: OSHA/ACGIH/NIOSH triple identical frozen OEL at 5 mg/m³ (all three agencies at identical 1971-era value; no US OEL update for REACH SVHC reproductive toxicant Category 1B + endocrine disruptor since 2012 EU classification; triple identical consensus at pre-reproductive-toxicology limit; ÷10 perturbation converts 50–80% utilization to displayed 5–8% — appearing exceptional while approaching the frozen SVHC limit; 6 pts) + REACH SVHC H360Df endocrine disruptor mechanism (REACH SVHC: reproductive toxicant Category 1B; endocrine disruptor confirmed by ECHA; DBP → MBP → PPARγ → anti-androgenic Leydig cell disruption; fetal testosterone suppression [phthalate syndrome]; H360Df developmental toxicant; female workers of reproductive age [pharmaceutical coating + medical device] highest H360Df risk; EU-US OEL gap; 4 pts) + three sectors (PVC plasticizer compounding [BASF Wyandotte MI] + pharmaceutical tablet CAP coating [Colorcon Harleysville PA] + medical device PVC extrusion [Integer Holdings Plano TX]; 5 pts) + three sites (3 pts) + FIRST (FIRST DBP CAS 84-74-2 triple identical frozen OEL + REACH SVHC reproductive toxicant + H360Df + endocrine disruptor AI EHS attack; FIRST DBP BASF Wyandotte MI; FIRST DBP Colorcon Harleysville PA pharmaceutical; FIRST DBP Integer Holdings Plano TX medical device; 3 pts). Total: 6+4+5+3+3 = 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
DBP_THRESHOLD = 21  # OSHA=ACGIH=NIOSH=5 mg/m3 triple identical frozen OEL; REACH SVHC repro toxicant 1B; H360Df

chemical = "dibutyl_phthalate_DBP_CAS_84-74-2"
osha_pel_mgm3 = 5.0       # TWA — 1971 frozen; AFL-CIO v. OSHA 1992 PEL-freeze; 55yr; no reproductive update
acgih_tlv_mgm3 = 5.0      # TLV-TWA A4 — identical to OSHA; no TLV reduction for REACH SVHC repro toxicant endpoint
niosh_rel_mgm3 = 5.0      # REL = OSHA = ACGIH — triple identical convergence at frozen 1971 value
reach_svhc = True         # EU REACH Annex XIV SVHC: reproductive toxicant 1B + endocrine disruptor; authorization since 2014
ghs_h360df = True         # H360Df: may damage fertility; may damage unborn child — reproductive toxicant Category 1B
triple_identical_frozen_oel = True  # OSHA=ACGIH=NIOSH=5 mg/m3; "false consensus" at pre-reproductive-tox value
mbp_metabolite_ppar_gamma = True    # MBP → PPARγ → anti-androgenic Leydig cell disruption mechanism

class DBPContext(StrEnum):
    BASF_WYANDOTTE_MI_PVC_COMPOUNDING                   = auto()  # Surface 1 (IOM NIOSH5020; 4.0→0.4 mg/m3; 43M 18yr)
    COLORCON_HARLEYSVILLE_PA_PHARMA_TABLET_COATING      = auto()  # Surface 2 (IOM NIOSH5020; 3.0→0.3 mg/m3; 36F 9yr)
    INTEGER_HOLDINGS_PLANO_TX_MEDICAL_DEVICE_PVC        = auto()  # Surface 3 (IOM NIOSH5020; 2.5→0.25 mg/m3; 31F 6yr)

class AdversarialDBPError(RuntimeError):
    def __init__(self, surface: DBPContext, score: int, frame_hash: str):
        super().__init__(
            f"DBP adversarial AI detected [{surface}] "
            f"score={score}/{DBP_THRESHOLD} hash={frame_hash}"
        )

async def scan_dbp_monitor_frame(image_path: Path, surface: DBPContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_mgm3": osha_pel_mgm3,
                "acgih_tlv_mgm3": acgih_tlv_mgm3,
                "niosh_rel_mgm3": niosh_rel_mgm3,
                "reach_svhc": reach_svhc,              # EU REACH Annex XIV; authorization required since 2014
                "ghs_h360df": ghs_h360df,              # reproductive toxicant 1B; developmental toxicant
                "triple_identical_frozen_oel": triple_identical_frozen_oel,
                "mbp_metabolite_ppar_gamma": mbp_metabolite_ppar_gamma,
                "female_reproductive_age_risk": True,  # pharmaceutical/medical sectors; H360Df risk
                "eu_us_oel_gap": True,                  # US OEL not updated vs EU REACH SVHC since 2012
                "pfl_freeze_year": 1971,
                "threshold": DBP_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= DBP_THRESHOLD:
            raise AdversarialDBPError(surface, result["score"], frame_hash)
        return result

See also: Styrene (CAS 100-42-5) — OSHA PEL 100 ppm vs ACGIH TLV-TWA 20 ppm A4 5× Gap + NIOSH Ca 50 ppm + IARC 2A NHL FRP/Boat-Building · HDI (CAS 822-06-0) — OSHA No PEL + ACGIH TLV 0.005 ppm A4 SEN SKIN + NIOSH Ca No REL Triple Vacuum Polyurethane · Glyphward scanner · All adversarial injection patterns